U.S. markets close in 4 hours 27 minutes
  • S&P 500

    4,649.59
    +82.59 (+1.81%)
     
  • Dow 30

    34,973.07
    +489.35 (+1.42%)
     
  • Nasdaq

    15,787.63
    +249.94 (+1.61%)
     
  • Russell 2000

    2,252.24
    +53.33 (+2.43%)
     
  • Crude Oil

    68.45
    +2.27 (+3.43%)
     
  • Gold

    1,786.20
    +9.70 (+0.55%)
     
  • Silver

    22.53
    -0.28 (-1.23%)
     
  • EUR/USD

    1.1335
    -0.0004 (-0.03%)
     
  • 10-Yr Bond

    1.4890
    +0.0460 (+3.19%)
     
  • GBP/USD

    1.3323
    +0.0021 (+0.16%)
     
  • USD/JPY

    112.9000
    -0.2800 (-0.25%)
     
  • BTC-USD

    58,785.91
    +1,335.82 (+2.33%)
     
  • CMC Crypto 200

    1,497.78
    +28.70 (+1.95%)
     
  • FTSE 100

    7,178.00
    +118.55 (+1.68%)
     
  • Nikkei 225

    27,935.62
    +113.86 (+0.41%)
     

Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B

·1 min read
  • Science 37, a life science company, is tapping the craze of a special purpose acquisition company to help it with a major public listing.

  • Specifically, its is penning a merger agreement with LifeSci Acquisition II Corp (NASDAQ: LSAQ).

  • According to its statement, the offering sees Science 37 valued at just over $1 billion and has $250 million to fund its decentralized trial tech platform and “extend into new adjacencies, and power the next generation in clinical research.”

  • The transaction will include a $200 million private placement from investors including BlackRock Inc., Lux Capital, Mubadala Investment Co., PPD Inc., and the SPAC sponsor’s affiliate, LifeSci Venture Partners.

  • It also includes up to $125 million of additional performance-based equity consideration. The company added that Science 37 shareholders “will retain their equity holdings.”

  • Science 37 and is expected to be listed on the Nasdaq under the ticker symbol “SNCE.”

  • According to its website, the company’s platform is used to conduct telehealth check-ins and administrative tasks such as securing patient consent agreements.

  • Price Action: LSAQ shares are up 7.14% at $10.81 during the market trading hours on the last check Friday.

Related content: Benzinga's Full SPAC Calendar

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.